[1] |
Zhang Xianzhong, Chen Xiaoyuan. Preparation and Characterization of 99Tcm(CO)3-BPy-RGD Complex as αvβ3 Integrin Receptor-Targeted Imaging Agent[J]. Appl Radiat Isot, 2007, 65: 70-78.
|
[2] |
李前伟.肿瘤整合素αvβ3受体显像的研究现状[J].国外医学-放射医学核医学分册,2003, 27(5): 198.
|
[3] |
Merdith J E, Fazeli B, Schwartz M A. The Extracellular Matrix as a Cell Survival Factor[J]. Mol Biol Cell, 1993, 4(9): 953-961.
|
[4] |
Brakebusch C, Bouvard D, Stanchi F, et al. Integrins in Invasive Growth[J]. J Clin Invest, 2002, 109: 999-1 006.
|
[5] |
Nicosia R F, Bonanno E. Inhibition of Angiogenesis in Vitro by RGD-Containing Synthetic Peptide [J]. Am J Pathol, 1991, 138: 829-833.
|
[6] |
De S, Razorenova O, McCabe N P, et al. VEGF-Integrin Interplay Controls Tumor Growth and Vascularization[J]. Proc Natl Acad Sci U S A, 2005, 102: 7 589-7 594.
|
[7] |
Robinson S D, Reynolds L E, Wyder L, et al. β3-Integrin Regulates Vascular Endothelial Growth Factor-A-Dependent Permeability[J]. Arterioscler Thromb Vasc Biol, 2004, 24: 2 108-2 114.
|
[8] |
Friedlander M, Brooks P C, Shaffer R W, et al. Definition of Two Angiogenic Pathways by Distinct αv Integrins[J]. Science, 1995, 270: 1 500-1 502.
|
[9] |
张雷.整合素与肿瘤[J].重庆医学,2003, 32(9): 1 261.
|
[10] |
Kim J W, Lee H S. Tumor Targeting by Doxorubicin-RGD-4C Peptide Conjugate in an Orthotopic Mouse Hepatoma Model [J]. Int J Mol Med, 2004, 14: 529-535.
|
[11] |
Chen X Y, Liu S, Hou Y P, et al. MicroPET Imaging of Breast Cancer αv-Integrin Expression With 64Cu-Labeled Dimeric RGD Peptides [J]. Mol Imag Biol, 2004, 6(5): 356-359.
|
[12] |
Chen X Y, Park R, Shahinian A H, et al. Pharmacokinetics and Tumor Retention of 125I-Labeled RGD Peptide are Improved by PEGylation [J]. Nucl Med Biol, 2004, 31: 11-19.
|
[13] |
Haubner R, Brucheritseifer M, Bock M, et al. Synthesis and Biological Evaluation of a 99Tcm-Labelled Cyclic RGD Peptide for Imaging αvβ3 Expression[J]. Nuklearmedizin, 2004, 43: 26-32.
|
[14] |
Psimadas D, Fani M, Zikos C, et al. Study of the Labeling of Two Novel RGD-Peptidic Derivatives With the Precursor [99Tcm(H2O)3(CO)3]+ and Evaluation for Early Angiogenesis Detection in Cancer [J]. Appl Radiat Isot, 2004, 31: 11-19.
|
[15] |
唐林,于俊峰,郑明强,等.铼[188Re]羰基化合物标记含RGD的环肽及其生物分布[J].核技术,2006, 29(6): 50-54.
|
[16] |
Dijkgraaf I, Kruijtzer J A W, Frielink C, et al. αvβ3 Integrin-Targeting of Intraperitoneally Growing Tumours With a Radiolabeled RGD Peptide [J]. Int J Cancer, 2006, 120: 605-610.
|
[17] |
Dijkgraaf I, Kruijtzer J A W, Liu S, et al. Improved Targeting of the αvβ3 Integrin by Multimerisation of RGD Peptides[J]. Eur J Nucl Med Mol Imag, 2007, 34: 267-273.
|
[18] |
Zhang X L, Zhang C F, Li J L, et al. Progress on Studying 188Re Labeled Peptide[J]. Nul Tech, 2002, 25(7): 587-592.
|
[19] |
Yu Junfeng, Hfeli Urs O, Xia Jiaoyun, et al. Radiolabelling of Poly(Histidine) Derivatized Biodegradable Microspheres With the 188Re Tricarbonyl Complex [188Re(CO)3(H2O)3]+ [J]. Nucl Med Comm, 2005, 26(5): 453-458.
|
[20] |
Wester H J. Molecular Targeting With Peptides or Peptide-Polymer Conjugates: Just a Question of Size[J]. J Nucl Med, 2005, 46(12): 1 940-1 945.
|